Closed 16 September 2027
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
European Commission (Horizon Europe)
- How much
- See the call
- Closing date
- 16 September 2027
- Opens
- 10 February 2027
- Where
- UK-wide
- Total fund
- HORIZON-MISS-2027-02-CANCER-03
- Who can apply
- Private Sector, Non-profit, Public Sector
- Aimed at
- Any sector
Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
How to apply
Apply through the EU Funding & Tenders portal. UK organisations can take part in Horizon Europe on the same terms as EU members. Many calls need a group of partners from different countries.
Taken from the funder's website. Last updated 7 November 2026.